Serelaxin may be more effective for relieving dyspnea in heart failure with preserved ejection fraction (HFpEF) than reduced (HFrEF) during the first 24 hours, according to results from RELAX-AHF presented in today's late ...
May 26, 2013
0
0
Heart failure patients who could possibly benefit from a newer class of drug to lower their heart rate were more likely to take the medication if it was prescribed before hospital discharge rather than in a follow-up doctor's ...
Apr 6, 2019
0
1
Sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with heart failure and mildly reduced or preserved ejection fraction, according to late breaking research presented in a Hot Line ...
Aug 26, 2022
0
22
(HealthDay)—Only one-in-five patients with heart failure with reduced ejection fraction (HFrEF) receive digoxin at discharge, according to a study published online Feb. 10 in JACC: Heart Failure.
Feb 12, 2016
0
1
(HealthDay) -- For younger adults with premature coronary artery disease (CAD), percutaneous coronary intervention (PCI) is associated with excellent short- and long-term outcomes, according to a study published in the June ...
Jun 6, 2012
0
0
An Australian research team led by QIMR Berghofer has succeeded in introducing a vascular system into tiny living and beating model human heart muscles, an achievement which it's hoped will accelerate progress toward the ...
Apr 27, 2023
0
101
Marian Dancy is a mother of four and a payroll specialist with a local law enforcement agency in Columbus, Ohio. Her fourth pregnancy was the easiest, giving her a third daughter to round out her family.
Jun 29, 2023
0
4
A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart's ability to contract properly. The research is presented at EACVI 2023, a scientific ...
May 10, 2023
0
70
A novel study from Karolinska Institutet in Sweden suggests that commonly used drugs to treat heart failure and high blood pressure may have a wider range of application than earlier known, and also can be used against so ...
Nov 27, 2012
0
0
(HealthDay)—Delivery of an SDF-1 encoding plasmid (JVS-100) acts a homing signal for stem cells and improves clinical status in patients with symptomatic heart failure due to ischemic cardiomyopathy (IsCM), according to ...
Feb 22, 2013
0
0
